Cabaletta Bio, Inc.
CABA
$1.59
-$0.03-1.85%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/11/2025
-
Zacks Investment Research
8/10/2025
-
MarketBeat
8/8/2025
-
GuruFocus
8/8/2025
-
The Fly
8/8/2025
-
TipRanks Financial Blog
8/8/2025
-
The Fly
8/7/2025
-
TipRanks Financial Blog
8/7/2025
-
GuruFocus
8/7/2025
-
Seeking Alpha - Healthcare
8/7/2025
-
Fool.com Headlines
8/7/2025
-
The Fly
8/7/2025
-
GuruFocus
8/7/2025
-
GuruFocus
8/7/2025
-
The Fly
8/7/2025
-
The Fly
8/7/2025
-
Globe Newswire
8/7/2025
-
MarketBeat
8/6/2025
-
MarketBeat
8/5/2025
-
TipRanks Financial Blog
7/25/2025
-
TipRanks Financial Blog
7/16/2025
-
TipRanks Financial Blog
7/12/2025
-
MarketBeat
7/9/2025
-
MarketBeat
6/25/2025
-
GuruFocus
6/17/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
267 759 3100
Address
2929 Arch Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Country
Year Founded
Business Description
Sector
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product...
more